Samar Alanazi

770 citations
13 papers · 575 indexed · 1 hit paper · h-index 8
Topics
HER2/EGFR in Cancer Research (6 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Melanoma and MAPK Pathways (3 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONECancer Research

In The Last Decade

Samar Alanazi

12 papers receiving 568 citations

Hit Papers

PI3K Inhibitors in Cancer: Clinical Implications and Adve...2021202620222024202150100150

Peers

Samar Alanazi
Comparison fields: 5 of 70
  • Molecular Biology 347
  • Oncology 271
  • Pulmonary and Respiratory Medicine 102
  • Radiology, Nuclear Medicine and Imaging 101
  • Cancer Research 66
Replace Rosalin Mishra with:
Rosalin Mishra United States
B. Markman Australia
Steve Guerrero United States
Mattia Cremona Ireland
Grit S. Herter-Sprie United States
Elisabeth Llonch Switzerland
Diana Spiegelberg Sweden
Santai Song China
Laura Vízkeleti Hungary
Andrew E. Aplin United States
Samar Alanazi relative to Rosalin Mishra United States Rosalin Mishra's profile →
Citations per field
00.5×1.5×
Rosalin Mishra · 1×
Citations per year

Countries citing papers authored by Samar Alanazi

Since Specialization
Citations

This map shows the geographic impact of Samar Alanazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Alanazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Alanazi more than expected).

Fields of papers citing papers by Samar Alanazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Alanazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Alanazi. The network helps show where Samar Alanazi may publish in the future.

Co-authorship network of co-authors of Samar Alanazi

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Alanazi. A scholar is included among the top collaborators of Samar Alanazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Alanazi. Samar Alanazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 1
2 4
3 1
4 13
5 0
6 19
7
PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effectsbreakdown →
194
8 2
9 18
10 132
11 23
12 140
13 28

About Samar Alanazi

Samar Alanazi is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Gastroenterology, having authored 13 papers that have together received 575 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Oncology (271 citations), Molecular Biology (347 citations) and Genetics (48 citations). Samar Alanazi has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Rosalin Mishra, Joan T. Garrett, Hima Patel, Long Yuan, Tarjani Thaker, Natalia Jura, Pankaj B. Desai, Edward J. Merino, Haizhou Zhu and Sarah J. Storr. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026